Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

NCT04765098 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Tamoxifen
DRUG: Etoposide

Sponsor

AHS Cancer Control Alberta